Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
the molecule remains investigational and is not approved for therapeutic use in any jurisdiction
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) must not be taken during pregnancy, while trying to get pregnant, or during breastfeeding and anyone who gets pregnant should stop using them immediately, the MHRA added
SURMOUNT trials demonstrated that 10 mg tirzepatide produces significant appetite suppression and weight loss through dual GLP-1 and GIP receptor activation
Early clinical trials suggest it may have very potent effects on weight and metabolic markers, but: It is not FDAapproved for weight loss or general wellness
In addition to the lean and ob/ob mice, the study included 3-KO mice and WT controls obtained from genetically verified breeding colonies
This may help support skin health and connective tissue function
